Growing community of inventors

Berlin, Germany

Daniel Olal

Average Co-Inventor Count = 7.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 5

Daniel OlalFelix Oden (3 patents)Daniel OlalStephen Marino (3 patents)Daniel OlalOliver Daumke (3 patents)Daniel OlalUta Höpken (3 patents)Daniel OlalMartin Lipp (3 patents)Daniel OlalGerd Müller (3 patents)Daniel OlalGerd M Muller (1 patent)Daniel OlalUta Hopken (1 patent)Daniel OlalMartin Lipp (1 patent)Daniel OlalDaniel Olal (3 patents)Felix OdenFelix Oden (9 patents)Stephen MarinoStephen Marino (9 patents)Oliver DaumkeOliver Daumke (6 patents)Uta HöpkenUta Höpken (4 patents)Martin LippMartin Lipp (3 patents)Gerd MüllerGerd Müller (3 patents)Gerd M MullerGerd M Muller (7 patents)Uta HopkenUta Hopken (1 patent)Martin LippMartin Lipp (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Max-delbruck-centrum Fur Molekulare Medizin (1 from 30 patents)

2. Max-delbruck-centrum Fur Molekulare Medizin in Der Helmholtz-gemeinschaft (1 from 21 patents)

3. Max-delrück-centrum Für Molekulare Medizin (1 from 1 patent)


3 patents:

1. 11667722 - Antibody that binds CD269 (BCMA) suitable for use in the treatment of plasma cell diseases such as multiple myeloma and autoimmune diseases

2. 10745486 - Antibody that binds CD269 (BCMA) suitable for use in the treatment of plasma cell diseases such as multiple myeloma and autoimmune diseases

3. 10189906 - Antibody that binds CD269 (BCMA) suitable for use in the treatment of plasma cell diseases such as multiple myeloma and autoimmune diseases

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/1/2026
Loading…